The Senior Leadership of the Virginia Commonwealth University (VCU) Massey Cancer Center (MCC) consists of the Director, scientific Associate Directors for Basic, Translational, Clinical, Cancer Prevention and Control Research, as well as an Associate Director for Shared Resources and an Associate Director for Research Administration and Finance. As a group, these leaders are responsible for the strategic scientific planning and tactical development of the MCC. Each of the Associate Directors provides direction for his or her area and promotes collaboration among the various areas. This Senior Leadership is complemented by the MCC strategy of Co-Leadership in each of the research programs. The translational programs have a basic science and clinical science teams of Co-Leaders, while the basic science programs are lead by Co- Leaders who have a major basic science research focus. The strength of this approach is manifested by the success of our scientific programs, as demonstrated in the overall growth of our cancer-focused research base and early phase clinical trials and translational research developed by our investigators. The Senior Leadership team is a stable, highly cohesive group of senior level cancer researchers who have successfully guided the MCC through its recent major growth in high impact collaborative scientific research and translational and clinical trial activities and established a strong positive trajectory for the future.

Public Health Relevance

The Senior Leadership of MCC is instrumental in assuring that MCC fulfills its mission as an NCI-designated cancer center. The Senior Leadership develops and implements the strategic plans that facilitate the basic, translational, and clinical research and transdisciplinary interactions of the MCC members, thus serving the public health mission of detecting, treating, and eliminating cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016059-32
Application #
8559583
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
32
Fiscal Year
2013
Total Cost
$552,085
Indirect Cost
$455,305
Name
Virginia Commonwealth University
Department
Type
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Yamada, Akimitsu; Nagahashi, Masayuki; Aoyagi, Tomoyoshi et al. (2018) ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer. Mol Cancer Res 16:1059-1070
Cantwell, Marc T; Farrar, Jared S; Lownik, Joseph C et al. (2018) STAT3 suppresses Wnt/?-catenin signaling during the induction phase of primary Myf5+ brown adipogenesis. Cytokine 111:434-444
Aqbi, Hussein F; Wallace, Matthew; Sappal, Samay et al. (2018) IFN-? orchestrates tumor elimination, tumor dormancy, tumor escape, and progression. J Leukoc Biol :
Volker, Sonja E; Hedrick, Shannon E; Feeney, Yvonne B et al. (2018) Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland. Cancer Res 78:3877-3887
Li, Xiaojiaoyang; Liu, Runping; Huang, Zhiming et al. (2018) Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans. Hepatology 68:599-615
Durant, Stephen T; Zheng, Li; Wang, Yingchun et al. (2018) The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci Adv 4:eaat1719
Damle, S R; Martin, R K; Cockburn, C L et al. (2018) ADAM10 and Notch1 on murine dendritic cells control the development of type 2 immunity and IgE production. Allergy 73:125-136
Wang, Feng; Li, Hongyan; Markovsky, Ela et al. (2018) Pazopanib radio-sensitization of human sarcoma tumors. Oncotarget 9:9311-9324
Stokes, Nancy A; Stanciu, Cristina E; Brocato, Emily R et al. (2018) Simplification of complex DNA profiles using front end cell separation and probabilistic modeling. Forensic Sci Int Genet 36:205-212
Poklepovic, Andrew; Qu, Yuesheng; Dickinson, Molly et al. (2018) Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers. Cardiooncology 4:

Showing the most recent 10 out of 586 publications